Patent Examiner Jeffrey Gerben Hoekstra
Art Unit 3791 · Physiological Measurement, Analyte Sensors & Sample Collection · Tech Center 3700 · 206 applications filed 2021–2026
Jeffrey Gerben Hoekstra is a USPTO patent examiner in Art Unit 3791 (Physiological Measurement, Analyte Sensors & Sample Collection) with 206 applications from filing years 2021–2026. Examiner Hoekstra's allowance rate is 62.0%, below the 84.3% USPTO average for applications filed in the same years. The examiner ranks harder than 81% of examiners. In 2023, decided applications with an examiner interview were allowed 35.7 percentage points more often than those without.
Data through November 2026 from USPTO Patent Center (formerly PAIR) · Methodology
Overview
FreeExaminer details
- Art unit3791 · Physiological Measurement, Analyte Sensors & Sample Collection
- Title / gradeSupervisory Patent Examiner · GS-15
- Service21 years
- PhoneOn each office action
- In USPTO recordsHOEKSTRA, JEFFREY GERBEN
Examiner Hoekstra can allow an application without a supervisory sign-off.
How to improve your odds with Examiner Hoekstra
- The data favors an interview. Interviewed cases were allowed more often in the one measured year, by 35.7 points.
- Plan for the timeline. First office action averages 846 days vs the 600-day USPTO norm.
- Expect a §102. Novelty is the most-issued rejection (116), and applicants overcame it 41.7% of the time.
- The data favors an RCE here. Cases with an RCE were allowed more often in both measured years, by 34.5 to 61.1 points.
Historical patterns from this examiner's past cases, shown for general information. This is not legal advice and does not predict the outcome of any specific application. Decisions about interviews, RCEs, and claim strategy should be made with a licensed patent attorney or agent.
Rejection patterns & how they get overcome
FreeApplicants overcame 20 of the 48 decided §102 novelty rejections from Examiner Hoekstra in the data. Each winning response, with its arguments and claim amendments, is in the file wrapper.
Just got an office action from Examiner Hoekstra?
Draft your response with Examiner Hoekstra's record and Art Unit 3791's history in view, including the rejection patterns, the interview record, and the arguments that have overcome them. See office action responses in AI Studio.
Trends
| Year | Interview rate | Allowance w/ interview | Allowance w/o | Delta |
|---|---|---|---|---|
| 2023 | 21.1% | 100.0% | 64.3% | +35.7pp |
RCE behavior
Allowance after a Request for Continued Examination versus without one, per year. Use it to judge whether an RCE is worth the cost in front of Examiner Hoekstra.
| Year | RCE rate | Allowance w/ RCE | Allowance w/o | Delta |
|---|---|---|---|---|
| 2023 | 23.3% | 100.0% | 65.5% | +34.5pp |
| 2022 | 31.7% | 100.0% | 38.9% | +61.1pp |
Recent outcomes
Free🔒 Case detail for members| App # | Title | Outcome | OAs | Arguments & redline |
|---|---|---|---|---|
| 18/784804 | Single-Arm Physiological Signal Measuring System | Patented | 1 | 🔒 View |
| 18/023729 | System and Method for Secondary Brain Insult Detection | Patented | 2 | 🔒 View |
| 18/125498 | Methods of Assessing Contact Between an Electrode and Tissue Using Complex Impedance Measurements | Patented | 1 | 🔒 View |
| 18/022816 | Method for Visual Function Assessment | Patented | 2 | 🔒 View |
Art Unit 3791 technology
Frequently asked questions
What is Examiner Jeffrey Gerben Hoekstra's allowance rate?
Is Examiner Hoekstra a hard examiner?
Do examiner interviews help with Examiner Hoekstra?
What is Examiner Hoekstra's most common rejection?
Is an RCE worth filing with Examiner Hoekstra?
How long until the first office action from Examiner Hoekstra?
Put Examiner Hoekstra's data to work on your next response.
Full file-wrapper detail, winning arguments, and AI-assisted drafting in one workspace.